AcertaPharma

About:

Acerta Pharma provides drug discovery and development services for oncology and autoimmune diseases.

Website: http://www.acerta-pharma.com

Top Investors: Frazier Healthcare Partners, BOM, BioGeneration Ventures

Description:

Acerta Pharma is focused on the development of covalent binding technology solutions to create therapies for cancer. Acerta Pharma was acquired by AstraZeneca in February 2016. Acerta Pharma was founded in 2013 and is based in San Carlos, California.

Total Funding Amount:

$60M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)acerta-pharma.com

Founders:

Ahmed Hamdy, Allard Kaptein, Francisco D. Salva, Raquel Izumi, Tjeerd Barf

Number of Employees:

51-100

Last Funding Date:

2013-03-14

IPO Status:

Private

Industries: